• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Medclair

2.32 SEK

-1.28 %

Less than 1K followers

MCLR

NGM Growth Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.28 %
-2.52 %
+0.87 %
-22.15 %
-15.64 %
+20.83 %
+91.74 %
-15.02 %
-18.76 %

Medclair is a Swedish cleantech company that develops technology for sustainable handling of nitrous oxide in healthcare, recycling and other industries using nitrous oxide. The company has an established international presence and offers solutions that aim to both reduce climate impact and improve the working environment. The headquarters are located in Stockholm.

Read more
Market cap
212.62M SEK
Turnover
361.75K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
20.8.
2026

Interim report Q2'26

5.11.
2026

Interim report Q3'26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release6/4/2026, 12:00 PM

Medclair strengthens the organization with key expertise in marketing and finance

Medclair
Press release5/28/2026, 6:00 AM

Medclair strengthens its position in French recycling – new deals and increased demand

Medclair
Regulatory press release5/7/2026, 6:00 AM

MEDCLAIR INTERIM REPORT JANUARY–MARCH 2026

Medclair

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Press release5/5/2026, 11:00 AM

Medclair Lowers Barriers to Global Billion-Scale Market – New Technology Accelerates Expansion and Strengthens Market Position

Medclair
Press release5/5/2026, 8:10 AM

Medclair: Q1 2026 Interim Report Presentation

Medclair
Press release4/29/2026, 8:40 AM

Medclair's technology enables compliance with strict new limit values – independent French study confirms results

Medclair
Regulatory press release4/22/2026, 4:05 PM

Communiqué from the Annual General Meeting of Medclair AB

Medclair
Press release4/22/2026, 7:30 AM

Veolia chooses Medclair for nitrous oxide destruction in new market

Medclair
Regulatory press release4/19/2026, 9:20 AM

Medclair AB – Nomination Committee’s Proposal

Medclair
Press release4/14/2026, 1:00 PM

Medclair featured in French national media

Medclair
Regulatory press release4/1/2026, 3:31 PM

Medclair - Annual Report 2025

Medclair
Press release3/31/2026, 11:45 AM

Medclair secures dual patents for new technology in nitrous oxide management

Medclair
Regulatory press release3/23/2026, 10:35 AM

Medclair receives follow-on order of SEK 5.4 million

Medclair
Regulatory press release3/20/2026, 11:15 AM

Notice of Annual General Meeting in Medclair AB (publ)

Medclair
Press release10/14/2025, 6:00 AM

Medclair enters new market - first installation in Belgium

Medclair
Press release10/9/2025, 7:15 AM

Medclair enters partnership with Litech

Medclair
Press release5/12/2025, 10:15 AM

European Study Positions Medclair as a Leading Provider of Sustainable Nitrous Oxide Solutions

Medclair